Biology and potential strategies for the treatment of GM2 gangliosidoses

This publication has 29 references indexed in Scilit:

• Formation of a ternary complex between GM2 activator protein, GM2 ganglioside and hexosaminidase A
  Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1997
• Heterozygote screening for Tay-Sachs disease
  Current Opinion in Pediatrics, 1996
• Significance of two point mutations present in each HEXB allele of patients with adult GM2 gangliosidosis (Sandhoff disease) Homozygosity for the Ile207 → Val substitution is not associated with a clinical or biochemical phenotype
  Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1996
• Mice lacking both subunits of lysosomal β–hexosaminidase display gangliosidosis and mucopolysaccharidosis
  Nature Genetics, 1996
• Dramatically Different Phenotypes in Mouse Models of Human Tay-Sachs and Sandhoff Diseases
  Human Molecular Genetics, 1996
• Disruption of murine Hexa gene leads to enzymatic deficiency and to neuronal lysosomal storage, similar to that observed in Tay-Sachs disease
  Mammalian Genome, 1995
• Targeted disruption of the Hexa gene results in mice with biochemical and pathologic features of Tay-Sachs disease.
  Proceedings of the National Academy of Sciences, 1994
• Growth of Ectopic Dendrites on Cortical Pyramidal Neurons in Neuronal Storage Diseases Correlates with Abnormal Accumulation of GM2 Ganglioside
  Journal of Neurochemistry, 1994
• The Clinical Aspects of Adult Hexosaminidase Deficiencies
  Developmental Neuroscience, 1991
• The biochemistry of HEXA and HEXB gene mutations causing GM2 gangliosidosis
  Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1991